Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 30609 | 135 | 24.1 | 66% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | SULOFENUR | Author keyword | 26 | 87% | 10% | 13 |
| 2 | LY295501 | Author keyword | 6 | 100% | 3% | 4 |
| 3 | ARYLSULFONYLIMIDAZOLIDINONE | Author keyword | 4 | 75% | 2% | 3 |
| 4 | DW2282 | Author keyword | 3 | 100% | 2% | 3 |
| 5 | N 1 SULFONYLCYTOSINE DERIVATIVES | Author keyword | 3 | 100% | 2% | 3 |
| 6 | DIARYLSULFONYLUREA | Author keyword | 2 | 31% | 4% | 5 |
| 7 | 4 PHENYL 1 ARYLSULFONYLIMIDAZOLIDINONE | Author keyword | 1 | 100% | 1% | 2 |
| 8 | ANAPLASTIC MAMMARY CARCINOMA | Author keyword | 1 | 100% | 1% | 2 |
| 9 | LY 186641 | Author keyword | 1 | 100% | 1% | 2 |
| 10 | N 1 SUBSTITUTED CYTOSINE | Author keyword | 1 | 100% | 1% | 2 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | SULOFENUR | 26 | 87% | 10% | 13 | Search SULOFENUR | Search SULOFENUR |
| 2 | LY295501 | 6 | 100% | 3% | 4 | Search LY295501 | Search LY295501 |
| 3 | ARYLSULFONYLIMIDAZOLIDINONE | 4 | 75% | 2% | 3 | Search ARYLSULFONYLIMIDAZOLIDINONE | Search ARYLSULFONYLIMIDAZOLIDINONE |
| 4 | DW2282 | 3 | 100% | 2% | 3 | Search DW2282 | Search DW2282 |
| 5 | N 1 SULFONYLCYTOSINE DERIVATIVES | 3 | 100% | 2% | 3 | Search N+1+SULFONYLCYTOSINE+DERIVATIVES | Search N+1+SULFONYLCYTOSINE+DERIVATIVES |
| 6 | DIARYLSULFONYLUREA | 2 | 31% | 4% | 5 | Search DIARYLSULFONYLUREA | Search DIARYLSULFONYLUREA |
| 7 | 4 PHENYL 1 ARYLSULFONYLIMIDAZOLIDINONE | 1 | 100% | 1% | 2 | Search 4+PHENYL+1+ARYLSULFONYLIMIDAZOLIDINONE | Search 4+PHENYL+1+ARYLSULFONYLIMIDAZOLIDINONE |
| 8 | ANAPLASTIC MAMMARY CARCINOMA | 1 | 100% | 1% | 2 | Search ANAPLASTIC+MAMMARY+CARCINOMA | Search ANAPLASTIC+MAMMARY+CARCINOMA |
| 9 | LY 186641 | 1 | 100% | 1% | 2 | Search LY+186641 | Search LY+186641 |
| 10 | N 1 SUBSTITUTED CYTOSINE | 1 | 100% | 1% | 2 | Search N+1+SUBSTITUTED+CYTOSINE | Search N+1+SUBSTITUTED+CYTOSINE |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | ARYLSULFONYLIMIDAZOLIDINONES | 31 | 92% | 9% | 12 |
| 2 | DIARYLSULFONYLUREAS | 27 | 70% | 17% | 23 |
| 3 | 4 PHENYL 1 ARYLSULFONYLIMIDAZOLIDINONES | 21 | 90% | 7% | 9 |
| 4 | SULOFENUR | 17 | 79% | 8% | 11 |
| 5 | LY186641 | 11 | 100% | 4% | 6 |
| 6 | ANTITUMOR DIARYLSULFONYLUREAS | 7 | 64% | 5% | 7 |
| 7 | ANTICANCER AGENT SULOFENUR | 6 | 100% | 3% | 4 |
| 8 | N 4 CHLOROPHENYLAMINOCARBONYL 2 3 DIHYDRO 1H INDENE 5 SULFONAMIDE LY186641 | 6 | 100% | 3% | 4 |
| 9 | N 1 SULFONYLCYTOSINE DERIVATIVES | 3 | 100% | 2% | 3 |
| 10 | N 4 METHYLPHENYLSULFONYL N 4 CHLOROPHENYLUREA | 3 | 100% | 2% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Novel sulphonamide derivatives for the treatment of cancer | 2000 | 76 | 65 | 43% |
| Chemotherapeutics and hormesis | 2003 | 18 | 93 | 6% |
| Parasitosis and cancer | 2008 | 0 | 16 | 13% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | BIOCHEM CLIN PHARMACOL DEV THER EUT S | 1 | 33% | 1.5% | 2 |
| 2 | DEV THER EUT S | 1 | 50% | 0.7% | 1 |
| 3 | VET ECON ANALYT EPIDEMIOL | 1 | 25% | 1.5% | 2 |
| 4 | DR BR AMBEDKAR VEEDHI | 0 | 33% | 0.7% | 1 |
| 5 | CANC CANADA CLIN TRIALS GRP | 0 | 17% | 0.7% | 1 |
| 6 | NUCL MED PATHOPHYSIOL | 0 | 17% | 0.7% | 1 |
| 7 | IST STUDIO NOUVI MAT ELETT | 0 | 100% | 0.7% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000239463 | 2 OXAZOLONE//2 THIAZOLONE//2 AMINO ALCOHOL |
| 2 | 0.0000211392 | CHEM TECHNOL DRUGS//2 MERCAPTOBENZENESULFONAMIDE//2 MERCAPTOBENZENESULFONAMIDES |
| 3 | 0.0000174845 | PHENOXODIOL//TNOX//ECTO NOX |
| 4 | 0.0000150880 | ELBS OXIDATION//QUIM MED JUAN CIERVA 3//2 5 DIHYDROXYPYRIDINES |
| 5 | 0.0000150096 | UNITE BIOTECHNOL BIOINGN//RECHUNITE BIOTECHNOL BIOINGN//COLCHICINE BINDING SITE LIGANDS |
| 6 | 0.0000134477 | DRUG RADIAT//M PRC//RADIOPROTECTIVE AGENTS |
| 7 | 0.0000131540 | RECH PHARMACOCHIM SUBST NAT SYNTHET//3 SUBSTITUTED 1 4 BENZODIAZEPINE//AMDA |
| 8 | 0.0000104217 | CHIM COORDINAT BIOORGAN BIOINORGAN//DESFERRIOXAMINE NITROXIDE RADICAL//SOY LIPOXYGENASE |
| 9 | 0.0000093168 | SUCCINIMIDES//N 3 5 DICHLOROPHENYLSUCCINIMIDE//N 1 NAPHTHYL SUCCINIMIDE |
| 10 | 0.0000088471 | CANINE ERYTHROCYTE//PYKNOCYTOSIS//HEINZ BODY |